EIC Summit 25 Networking Platform

2–3 Apr 2025 | Brussels, Belgium

Genbioma Aplicaciones S.L.

Start-ups and SMEs

www.genbioma.comNavarra, Spain
2 profile visits

About

Metabolic Health through Microbiome Science. Precision Postbiotics to prevent glucose metabolic disorders and improve human health.

Our mission is simple: to improve people's health through microbiome products (probiotics and postbiotics). By targeting the gut microbiota with specific strains, we can regulate glucose and lipid metabolism to improve health (diabetes, obesity, hypercholesterolemia).

The microbiome has countless applications in health. To this end, we have created a platform to develop natural and safe nutritional ingredients and supplements that regulate metabolism through the balance of the intestinal microbiota.

Our cutting-edge technology and microbiome science are based on rapid detection of bacterial strains by using the C. elegans model to rapidly search for potential in health goals. Our first portfolio of microbiome solutions for people with type 2 diabetes (T2D), prediabetes (preD), and obesity. We use state-of-the-art metagenomic and metabolomic tools and our rapid bacterial strain detection platform in C. elegans to quickly search for health targets. By targeting the gut microbiota with specific postbiotic products, we can improve metabolic health and also help prevent and reverse disease progression

Our business strategy is to operate within a B2B framework spanning the pharma and food sectors.

Social media

Objectives

Looking for investments

Topics

Health Biotechnology

Representatives

Josune Ayo

CoFounder & CEO

Genbioma Aplicaciones S.L.

Marketplace (2)

  • Investment

    GENBIOMA SERIES A

    Looking for invertors for a new round Series A in Q4 2025

    • Expansion
    • Growth and Establishment
    Author

    Josune Ayo

    CoFounder & CEO at Genbioma Aplicaciones S.L.

    Navarra, Navarra, Spain